The Blood Ontology: An ontology in the domain of hematology by Barcellos, Almeida Mauricio et al.
 The Blood Ontology: 
An Ontology in the Domain of Hematology  
Mauricio Barcellos Almeida1, Anna Barbara de Freitas Carneiro Proietti2, Jiye Ai3, Barry Smith4 
1Federal University of Minas Gerais, School of Information Science, Belo Horizonte, Brazil 
2Hemominas Foundation, Belo Horizonte, Brazil 
3University of California, Los Angeles, School of Dentistry and Dental Research Institute, USA 
4State University of New York at Buffalo, USA 
 
Abstract. Despite the importance of human blood to clinical practice and research, 
hematology and blood transfusion data remain scattered throughout a range of disparate 
sources. This lack of systematization concerning the use and definition of terms poses 
problems for physicians and biomedical professionals. We are introducing here the Blood 
Ontology, an ongoing initiative designed to serve as a controlled vocabulary for use in 
organizing information about blood. The paper describes the scope of the Blood Ontology, 
its stage of development and some of its anticipated uses.  
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1  Background 
The biomedical field is vast and complex and 
the representation of medical facts is also a 
complex task. The complexity and importance 
of the medical domain require representation 
as consistent as that offered by ontologies. The 
profusion of medical ontologies seen in recent 
years and the appearance of open data 
repositories, such as the Open Biomedical 
Ontologies Foundry [1], can attest to the 
feasibility of this approach for the life 
sciences.  
Within this context, we introduce the 
Blood Ontology (BLO), which has been 
designed to serve as a comprehensive 
infrastructure resource allowing for the 
exploration of information relevant to 
scientific research and human blood 
manipulation. The BLO is part of a long-term 
ongoing knowledge management project in the 
field of hematology and blood transfusion, 
structured according to three main axes: i) 
knowledge organization based on ontological 
principles; ii) knowledge acquisition from 
experts and texts; and iii) visualization tools. 
In this paper, we describe the BLO and its 
current stage of development. 
 
2  Methods 
The BLO consists of a set of co-related 
ontologies, each one addressing a group of 
relevant issues in the field of hematology and 
blood transfusion. These sub-ontologies are: i) 
BLO-Core, an ontology of hematological 
essentials; ii) BLO-Management, an ontology 
for the management of blood-related 
processes; iii) BLO-Products, an ontology 
representing the products resulting from blood 
manipulation; and iv) BLO-Administrative, an 
ontology for regulatory documents.  
In the current stage, the main activities 
being performed for BLO-Core are: i) the 
collection of terms from the domain of 
hematology; ii) reuse of data available in other 
ontologies; iii) organization of a hierarchy and 
prospective studies of relationships.  
Knowledge acquisition is being 
undertaken by experts in biology and 
medicine, who are members of the 
Hemominas Foundation1, the second largest 
Brazilian blood bank. We have been using the 
following methods: i) interviews oriented 
according to forms created in Protégé-Frames, 
which are based on the Ontology for General 
Medical Science (OGMS) [2]; ii) validation of 
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 knowledge acquired using a semantic wiki; iii) 
translation of validated terms from the wiki to 
Protégé-OWL. 
With the aim of fostering interoperability 
among ontologies, the BLO relies on well-
consolidated initiatives, namely those 
pertaining to the OBO Foundry framework 
[4]. Within the OBO scope, important 
initiatives are the Gene Ontology [3], the 
Protein Ontology [4], the Cell-Type Ontology 
[5], to mention but a few. BLO also relies on 
the foundational grounds of the Basic Formal 
Ontology [6], an upper-level ontology created 
to support scientific research. In order to 
gather such ontologies we have adopted the 
experimental approach called Minimal 
Information to Reference External Ontology 
Terms (MIREOT) [7], which was developed as 
part of the Ontology for Biomedical 
Investigations project [8]. 
3  Results 
This section describes the current stage of 
development of each BLO sub-ontology, as 
well as the planned scope of future 
developments. 
The BLO-Core focuses on physiological 
aspects of blood and presents the basic 
information required to work on hematological 
research and practice. The ontology provides 
the essentials of the chemical constituents and 
of the molecular, immunologic and cellular 
basis of blood, as well as blood disorders and 
transplantation. Currently, more than eight 
hundred terms have been defined and in-
corporated into the Core subset. (Preliminary 
results are available at: http://mbaserver. 
eci.ufmg.br/BLO-wiki/index.php/BLO_Core) 
The ontology named BLO-Management 
covers the relevant processes involved in blood 
manipulation and related services. Blood 
manipulation involves primarily the following 
activities: i) quality management; ii) blood 
utilization management; iii) donor selection; 
iv) blood collection; v) control of transfusions; 
vi) control of apheresis; vii) blood testing. In 
turn, these activities involve a range of 
processes that were considered in the design 
of BLO-Management. This branch of the BLO 
is under development involving natural 
language processing techniques applied to a 
set of documents from the American 
Association of Blood Banks. 
The BLO-Products ontology is aimed at 
facing the challenges created by a multitude of 
possible “product” derivates of blood 
manipulation managed on a worldwide scale.  
It is mainly based on studies about ISBT-128 
[9], an internationally defined labeling 
system. ISBT-128 standardizes a bar-coded 
symbology for blood products, allowing them 
to be read at blood banks and transfusion 
services around the world.  
A standard as ISBT has proven to be of 
practical importance, but it allows for the 
ambiguities that are common in a natural 
language. This branch of the BLO is under 
development and the results are also partial. 
The research involves the evaluation of rules 
used to create IBST terms and descriptors in 
order to check ontological decisions underlying 
that standard. 
The BLO-Administrative ontology is 
aimed at covering the issues related to the 
official documentation of interest to blood 
banks and transfusion services. By 
“documentation”, we mean policies, documents 
from regulatory agencies, professional class 
associations, law, regulations, officially 
recognized classification systems, and 
standards. BLO-Administrative is being 
designed in line with the Information Artifact 
Ontology (IAO) [10]. The results here are 
partial and concern attempts to create an 
additional characterization for documents 
based on a pragmatic approach. Examples of 
the kinds of documents being evaluated are: 
blood donation orders, consent letters, quality 
requirements, to mention but a few. 
4  Discussion 
The BLO serves several purposes, for 
example: as the core vocabulary for the 
development of interoperable systems, as a 
base for computational inferences, as a 
knowledge base for educational purposes, as a 
tool to aid in information for diagnosis.  
The importance of a diagnosis based on 
the components of blood resides in the fact 
that blood cells are accessible indicators of 
disturbances in their organs of origin. During 
illness, abnormalities can develop in any of 
the cells in the blood and their detection may 
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 aid in diagnosis, as well as in the care of 
patients.  
The BLO also considers the broader 
perspective of human fluids [11]. It is worth 
mentioning the collaboration between the 
BLO and the Saliva Ontology (SALO, 
http://www.skb.ucla.edu/SALO/). SALO is a 
consensus-based controlled vocabulary of 
terms and relationships related to the 
salivaomics domain [12]. It relies on research 
on salivary diagnostic technologies being 
developed by the UCLA Salivaomics Research 
Group.  
The BLO is being specialized, for example, 
for use by the Hemominas Foundation 
research group, which focuses mainly on the 
studies of blood transmitted diseases (HIV-
1/2, hepatitis B and C, among others), 
hemophilias, Von-Willebrand disease, Sickle 
Cell Anemia and Human T-cell Lymphotropic 
Virus. 
These initiatives have been designed to be 
aligned with the Infectious Disease Ontology 
(IDO, http://www.infectiousdiseaseontology. 
org), which is an initiative that gathers 
together a set of ontologies covering the 
infectious disease domain.  
5  Conclusion 
In this paper, we presented the BLO as an 
ongoing initiative, developed with the aim of 
facilitating the access to, use and analysis of 
data on blood. The medical field is a broad and 
highly developed system to which both 
medical science and clinical practice 
contribute. The importance of the BLO resides 
in the realization that, despite all the 
advances of recent years, many medical 
processes pertaining to human blood are still 
not fully understood. 
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